Evidence map›Paper›PMID 31323977›Full record

ArticleMarine drugs2019

Young-Jin Seo, Kippeum Lee, Sungwoo Chei, You-Jin Jeon, Boo-Yong Lee

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. A Novel Blend ofFoods (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Effect ofFrontiers in nutrition · 2022
    Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Young-Jin SeoDepartment of Food Science and Biotechnology, College of Life Science, CHA University, Seongnam, Kyeonggi 13488, Korea.
Kippeum LeeDepartment of Food Science and Biotechnology, College of Life Science, CHA University, Seongnam, Kyeonggi 13488, Korea.
Sungwoo CheiDepartment of Food Science and Biotechnology, College of Life Science, CHA University, Seongnam, Kyeonggi 13488, Korea.
You-Jin JeonDepartment of Food Science and Biotechnology, College of Life Science, CHA University, Seongnam, Kyeonggi 13488, Korea.
Boo-Yong LeeDepartment of Food Science and Biotechnology, College of Life Science, CHA University, Seongnam, Kyeonggi 13488, Korea. bylee@cha.ac.kr.
CHA University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus and related metabolic disorders, such as dyslipidemia, present increasing challenges to health worldwide, as a result of urbanization, the increasing prevalence of obesity, poor lifestyle, and other stress-related factors.

Indexed as

AdiposityAnimalsBlood GlucoseDiabetes Mellitus, Type 2Disease Models, AnimalEnergy MetabolismFibroblast Growth FactorsGlucose Transporter Type 4HumansHyperglycemiaInsulin Receptor Substrate ProteinsMaleMiceMice, Inbred ICRMice, TransgenicPhaeophyceaeBlood Glucosefibroblast growth factor 21Fibroblast Growth FactorsGlucose Transporter Type 4Insulin Receptor Substrate ProteinsPhosphatidylinositol 3-KinasesPlant ExtractsProto-Oncogene Proteins c-aktSlc2a4 protein, mousedb/db mousefibroblast growth factor 21hyperglycemiainsulin receptor substrate 1/phosphatidylinositol 3-kinase/Akt pathwayIshige okamurae

Identifiers

PMID31323977
PMCPMC6669686
OpenAlexW2957077697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.